Cyanotech Corporation Logo

Cyanotech Corporation

CYAN

(1.0)
Stock Price

0,69 USD

-14.93% ROA

-30.97% ROE

-1.37x PER

Market Cap.

6.197.940,00 USD

78.15% DER

0% Yield

-20.52% NPM

Cyanotech Corporation Stock Analysis

Cyanotech Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cyanotech Corporation Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.3x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock maintains a fair debt to equity ratio (76%), indicating a reasonable balance between the money it owes and the ownership it possesses.

3 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

4 ROE

Negative ROE (-26.35%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-15.24%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-4) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Cyanotech Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cyanotech Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Cyanotech Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cyanotech Corporation Revenue
Year Revenue Growth
1989 1.100.000
1990 1.900.000 42.11%
1991 1.800.000 -5.56%
1992 2.500.000 28%
1993 2.700.000 7.41%
1994 4.200.000 35.71%
1995 8.100.000 48.15%
1996 11.400.000 28.95%
1997 7.600.000 -50%
1998 6.700.000 -13.43%
1999 7.398.000 9.43%
2000 8.043.000 8.02%
2001 8.235.000 2.33%
2002 8.951.000 8%
2003 11.582.000 22.72%
2004 11.445.000 -1.2%
2005 11.131.000 -2.82%
2006 9.683.000 -14.95%
2007 11.364.000 14.79%
2008 13.950.000 18.54%
2009 15.742.000 11.38%
2010 16.827.000 6.45%
2011 24.631.000 31.68%
2012 27.581.000 10.7%
2013 28.905.000 4.58%
2014 33.809.000 14.51%
2015 31.840.000 -6.18%
2016 32.042.000 0.63%
2017 34.115.000 6.08%
2018 30.202.000 -12.96%
2019 31.899.000 5.32%
2020 32.345.000 1.38%
2021 35.968.000 10.07%
2022 23.178.000 -55.18%
2023 25.492.000 9.08%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cyanotech Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 100.000 100%
1994 200.000 50%
1995 400.000 50%
1996 600.000 33.33%
1997 700.000 14.29%
1998 900.000 22.22%
1999 514.000 -75.1%
2000 265.000 -93.96%
2001 343.000 22.74%
2002 217.000 -58.06%
2003 149.000 -45.64%
2004 257.000 42.02%
2005 192.000 -33.85%
2006 203.000 5.42%
2007 143.000 -41.96%
2008 206.000 30.58%
2009 264.000 21.97%
2010 282.000 6.38%
2011 320.000 11.88%
2012 258.000 -24.03%
2013 469.000 44.99%
2014 517.000 9.28%
2015 633.000 18.33%
2016 593.000 -6.75%
2017 563.000 -5.33%
2018 923.000 39%
2019 608.000 -51.81%
2020 639.000 4.85%
2021 712.000 10.25%
2022 770.000 7.53%
2023 700.000 -10%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cyanotech Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1989 0
1990 900.000 100%
1991 900.000 0%
1992 1.000.000 10%
1993 0 0%
1994 1.000.000 100%
1995 1.600.000 37.5%
1996 2.500.000 36%
1997 2.800.000 10.71%
1998 2.700.000 -3.7%
1999 2.505.000 -7.78%
2000 1.700.000 -47.35%
2001 3.404.000 50.06%
2002 0 0%
2003 0 0%
2004 0 0%
2005 1.883.000 100%
2006 0 0%
2007 2.478.000 100%
2008 2.873.000 13.75%
2009 3.311.000 13.23%
2010 2.822.000 -17.33%
2011 4.014.000 29.7%
2012 4.680.000 14.23%
2013 6.415.000 27.05%
2014 7.864.000 18.43%
2015 5.785.000 -35.94%
2016 6.054.000 4.44%
2017 4.956.000 -22.15%
2018 5.718.000 13.33%
2019 5.281.000 -8.27%
2020 4.876.000 -8.31%
2021 5.367.000 9.15%
2022 4.659.000 -15.2%
2023 4.640.000 -0.41%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cyanotech Corporation EBITDA
Year EBITDA Growth
1989 -1.900.000
1990 200.000 1050%
1991 -300.000 166.67%
1992 300.000 200%
1993 300.000 0%
1994 1.000.000 70%
1995 3.100.000 67.74%
1996 3.900.000 20.51%
1997 400.000 -875%
1998 -1.300.000 130.77%
1999 2.604.000 149.92%
2000 1.968.000 -32.32%
2001 -759.000 359.29%
2002 426.000 278.17%
2003 2.115.000 79.86%
2004 1.893.000 -11.73%
2005 1.261.000 -50.12%
2006 -6.016.000 120.96%
2007 -308.000 -1853.25%
2008 1.747.000 117.63%
2009 2.017.000 13.39%
2010 1.846.000 -9.26%
2011 3.598.000 48.69%
2012 3.192.000 -12.72%
2013 1.297.000 -146.11%
2014 1.661.000 21.91%
2015 746.000 -122.65%
2016 1.296.000 42.44%
2017 3.291.000 60.62%
2018 -1.089.000 402.2%
2019 3.281.000 133.19%
2020 2.149.000 -52.68%
2021 4.495.000 52.19%
2022 -825.000 644.85%
2023 -424.000 -94.58%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cyanotech Corporation Gross Profit
Year Gross Profit Growth
1989 -1.400.000
1990 1.100.000 227.27%
1991 600.000 -83.33%
1992 1.400.000 57.14%
1993 1.400.000 0%
1994 2.300.000 39.13%
1995 5.100.000 54.9%
1996 7.500.000 32%
1997 4.100.000 -82.93%
1998 2.300.000 -78.26%
1999 2.906.000 20.85%
2000 3.667.000 20.75%
2001 1.562.000 -134.76%
2002 2.895.000 46.04%
2003 3.940.000 26.52%
2004 3.818.000 -3.2%
2005 3.299.000 -15.73%
2006 1.131.000 -191.69%
2007 3.071.000 63.17%
2008 5.512.000 44.29%
2009 6.633.000 16.9%
2010 6.341.000 -4.6%
2011 9.774.000 35.12%
2012 10.958.000 10.8%
2013 11.564.000 5.24%
2014 14.466.000 20.06%
2015 11.866.000 -21.91%
2016 12.224.000 2.93%
2017 13.371.000 8.58%
2018 10.466.000 -27.76%
2019 12.700.000 17.59%
2020 11.117.000 -14.24%
2021 13.566.000 18.05%
2022 7.259.000 -86.89%
2023 8.352.000 13.09%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cyanotech Corporation Net Profit
Year Net Profit Growth
1989 -1.500.000
1990 -300.000 -400%
1991 -700.000 57.14%
1992 300.000 333.33%
1993 200.000 -50%
1994 800.000 75%
1995 2.500.000 68%
1996 4.200.000 40.48%
1997 -300.000 1500%
1998 -2.600.000 88.46%
1999 -4.485.000 42.03%
2000 -1.067.000 -320.34%
2001 -2.589.000 58.79%
2002 -1.775.000 -45.86%
2003 399.000 544.86%
2004 486.000 17.9%
2005 -268.000 281.34%
2006 -7.425.000 96.39%
2007 -1.139.000 -551.89%
2008 1.142.000 199.74%
2009 1.391.000 17.9%
2010 1.730.000 19.6%
2011 3.632.000 52.37%
2012 4.209.000 13.71%
2013 -195.000 2258.46%
2014 -24.000 -712.5%
2015 -4.395.000 99.45%
2016 -1.215.000 -261.73%
2017 1.025.000 218.54%
2018 -3.596.000 128.5%
2019 387.000 1029.2%
2020 920.000 57.93%
2021 2.154.000 57.29%
2022 -3.440.000 162.62%
2023 -3.188.000 -7.9%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cyanotech Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1989 0
1990 0 0%
1991 -1 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 1 0%
1996 1 100%
1997 0 0%
1998 -1 0%
1999 -1 100%
2000 0 0%
2001 -1 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 -1 100%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 1 0%
2012 1 0%
2013 0 0%
2014 0 0%
2015 -1 0%
2016 0 0%
2017 0 0%
2018 -1 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 -1 0%
2023 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cyanotech Corporation Free Cashflow
Year Free Cashflow Growth
1990 -500.000
1991 -200.000 -150%
1992 300.000 166.67%
1993 -1.200.000 125%
1994 -400.000 -200%
1995 -1.300.000 69.23%
1996 -4.100.000 68.29%
1997 -4.900.000 16.33%
1998 -900.000 -444.44%
1999 -54.000 -1566.67%
2000 -194.000 72.16%
2001 -949.000 79.56%
2002 -752.000 -26.2%
2003 1.553.000 148.42%
2004 679.000 -128.72%
2005 -132.000 614.39%
2006 -733.000 81.99%
2007 -913.000 19.72%
2008 459.000 298.91%
2009 187.000 -145.45%
2010 1.233.000 84.83%
2011 3.053.000 59.61%
2012 -1.997.000 252.88%
2013 -1.968.000 -1.47%
2014 -3.059.000 35.67%
2015 -3.558.000 14.02%
2016 373.000 1053.89%
2017 485.000 23.09%
2018 -1.278.000 137.95%
2019 1.019.000 225.42%
2020 1.640.000 37.87%
2021 1.109.000 -47.88%
2022 -3.168.000 135.01%
2023 698.000 553.87%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cyanotech Corporation Operating Cashflow
Year Operating Cashflow Growth
1990 -500.000
1991 -100.000 -400%
1992 300.000 133.33%
1993 600.000 50%
1994 1.000.000 40%
1995 2.600.000 61.54%
1996 2.900.000 10.34%
1997 1.000.000 -190%
1998 -900.000 211.11%
1999 343.000 362.39%
2000 243.000 -41.15%
2001 -567.000 142.86%
2002 -502.000 -12.95%
2003 1.966.000 125.53%
2004 1.328.000 -48.04%
2005 179.000 -641.9%
2006 -459.000 139%
2007 -782.000 41.3%
2008 908.000 186.12%
2009 1.219.000 25.51%
2010 1.747.000 30.22%
2011 5.082.000 65.62%
2012 1.897.000 -167.9%
2013 2.149.000 11.73%
2014 1.239.000 -73.45%
2015 745.000 -66.31%
2016 1.220.000 38.93%
2017 1.490.000 18.12%
2018 -847.000 275.91%
2019 1.243.000 168.14%
2020 2.400.000 48.21%
2021 2.379.000 -0.88%
2022 -2.100.000 213.29%
2023 834.000 351.8%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cyanotech Corporation Capital Expenditure
Year Capital Expenditure Growth
1990 0
1991 100.000 100%
1992 0 0%
1993 1.800.000 100%
1994 1.400.000 -28.57%
1995 3.900.000 64.1%
1996 7.000.000 44.29%
1997 5.900.000 -18.64%
1998 0 0%
1999 397.000 100%
2000 437.000 9.15%
2001 382.000 -14.4%
2002 250.000 -52.8%
2003 413.000 39.47%
2004 649.000 36.36%
2005 311.000 -108.68%
2006 274.000 -13.5%
2007 131.000 -109.16%
2008 449.000 70.82%
2009 1.032.000 56.49%
2010 514.000 -100.78%
2011 2.029.000 74.67%
2012 3.894.000 47.89%
2013 4.117.000 5.42%
2014 4.298.000 4.21%
2015 4.303.000 0.12%
2016 847.000 -408.03%
2017 1.005.000 15.72%
2018 431.000 -133.18%
2019 224.000 -92.41%
2020 760.000 70.53%
2021 1.270.000 40.16%
2022 1.068.000 -18.91%
2023 136.000 -685.29%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cyanotech Corporation Equity
Year Equity Growth
1989 -1.100.000
1990 1.500.000 173.33%
1991 1.100.000 -36.36%
1992 1.500.000 26.67%
1993 4.200.000 64.29%
1994 5.100.000 17.65%
1995 17.300.000 70.52%
1996 23.300.000 25.75%
1997 23.200.000 -0.43%
1998 20.700.000 -12.08%
1999 16.645.000 -24.36%
2000 15.695.000 -6.05%
2001 13.191.000 -18.98%
2002 12.273.000 -7.48%
2003 14.440.000 15.01%
2004 15.080.000 4.24%
2005 14.817.000 -1.77%
2006 7.510.000 -97.3%
2007 6.379.000 -17.73%
2008 7.774.000 17.94%
2009 9.120.000 14.76%
2010 11.111.000 17.92%
2011 15.265.000 27.21%
2012 20.227.000 24.53%
2013 20.847.000 2.97%
2014 21.483.000 2.96%
2015 17.828.000 -20.5%
2016 16.607.000 -7.35%
2017 18.107.000 8.28%
2018 14.909.000 -21.45%
2019 15.846.000 5.91%
2020 17.041.000 7.01%
2021 19.487.000 12.55%
2022 16.347.000 -19.21%
2023 14.407.000 -13.47%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cyanotech Corporation Assets
Year Assets Growth
1989 2.800.000
1990 3.000.000 6.67%
1991 2.600.000 -15.38%
1992 2.700.000 3.7%
1993 5.100.000 47.06%
1994 6.200.000 17.74%
1995 19.700.000 68.53%
1996 26.000.000 24.23%
1997 25.700.000 -1.17%
1998 23.600.000 -8.9%
1999 19.689.000 -19.86%
2000 21.423.000 8.09%
2001 18.400.000 -16.43%
2002 17.482.000 -5.25%
2003 18.357.000 4.77%
2004 18.542.000 1%
2005 17.473.000 -6.12%
2006 9.906.000 -76.39%
2007 9.780.000 -1.29%
2008 10.787.000 9.34%
2009 12.148.000 11.2%
2010 13.860.000 12.35%
2011 19.038.000 27.2%
2012 28.587.000 33.4%
2013 30.310.000 5.68%
2014 30.915.000 1.96%
2015 31.147.000 0.74%
2016 29.161.000 -6.81%
2017 29.707.000 1.84%
2018 29.626.000 -0.27%
2019 31.787.000 6.8%
2020 30.879.000 -2.94%
2021 32.045.000 3.64%
2022 29.728.000 -7.79%
2023 28.082.000 -5.86%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cyanotech Corporation Liabilities
Year Liabilities Growth
1989 3.900.000
1990 1.500.000 -160%
1991 1.500.000 0%
1992 1.200.000 -25%
1993 900.000 -33.33%
1994 1.100.000 18.18%
1995 2.400.000 54.17%
1996 2.700.000 11.11%
1997 2.500.000 -8%
1998 2.900.000 13.79%
1999 3.044.000 4.73%
2000 5.728.000 46.86%
2001 5.209.000 -9.96%
2002 5.209.000 0%
2003 3.917.000 -32.98%
2004 3.462.000 -13.14%
2005 2.656.000 -30.35%
2006 2.396.000 -10.85%
2007 3.401.000 29.55%
2008 3.013.000 -12.88%
2009 3.028.000 0.5%
2010 2.749.000 -10.15%
2011 3.773.000 27.14%
2012 8.360.000 54.87%
2013 9.463.000 11.66%
2014 9.432.000 -0.33%
2015 13.319.000 29.18%
2016 12.554.000 -6.09%
2017 11.600.000 -8.22%
2018 14.717.000 21.18%
2019 15.941.000 7.68%
2020 13.838.000 -15.2%
2021 12.558.000 -10.19%
2022 13.381.000 6.15%
2023 13.675.000 2.15%

Cyanotech Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
3.58
Net Income per Share
-0.66
Price to Earning Ratio
-1.37x
Price To Sales Ratio
0.27x
POCF Ratio
9.58
PFCF Ratio
-93.91
Price to Book Ratio
0.4
EV to Sales
0.71
EV Over EBITDA
-11.59
EV to Operating CashFlow
27.13
EV to FreeCashFlow
-245.77
Earnings Yield
-0.73
FreeCashFlow Yield
-0.01
Market Cap
0,01 Bil.
Enterprise Value
0,02 Bil.
Graham Number
5.79
Graham NetNet
-1.03

Income Statement Metrics

Net Income per Share
-0.66
Income Quality
-0.14
ROE
-0.26
Return On Assets
-0.17
Return On Capital Employed
-0.21
Net Income per EBT
1
EBT Per Ebit
1.17
Ebit per Revenue
-0.18
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0.2
Research & Developement to Revenue
0.03
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.3
Operating Profit Margin
-0.18
Pretax Profit Margin
-0.2
Net Profit Margin
-0.21

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.09
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
-1.11
Capex to Revenue
-0.03
Capex to Depreciation
-0.32
Return on Invested Capital
-0.12
Return on Tangible Assets
-0.15
Days Sales Outstanding
22.89
Days Payables Outstanding
31.69
Days of Inventory on Hand
218.37
Receivables Turnover
15.95
Payables Turnover
11.52
Inventory Turnover
1.67
Capex per Share
-0.1

Balance Sheet

Cash per Share
0,19
Book Value per Share
2,26
Tangible Book Value per Share
2.26
Shareholders Equity per Share
2.26
Interest Debt per Share
1.88
Debt to Equity
0.78
Debt to Assets
0.4
Net Debt to EBITDA
-7.16
Current Ratio
1.46
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0.78
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
10048500
Debt to Market Cap
1.82

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cyanotech Corporation Dividends
Year Dividends Growth

Cyanotech Corporation Profile

About Cyanotech Corporation

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

CEO
Mr. Matthew Keith Custer
Employee
86
Address
73-4460 Queen Kaahumanu Highway
Kailua-Kona, 96740

Cyanotech Corporation Executives & BODs

Cyanotech Corporation Executives & BODs
# Name Age
1 Mr. Charles J. Hartmann
Vice President of Sales & Marketing
70
2 Ms. Collette Kakuk
Chief Strategic & Commercial Officer
70
3 Mr. Matthew Keith Custer
President, Chief Executive Officer & Director
70
4 Mr. Glenn D. Jensen
Vice President of Operations
70
5 Ms. Amy Beth Nordin
Vice President of Human Resources & Corporate Secretary
70
6 Ms. Felicia I. Ladin
Chief Financial Officer & Vice President of Finance & Administration and Treasurer
70
7 Dr. Gerald R. Cysewski Ph.D.
Co-Founder, Chief Executive Officer Emeritus & Chief Scientific Officer
70

Cyanotech Corporation Competitors